
Marc S. Hoff
Examiner (ID: 9849)
| Most Active Art Unit | 2104 |
| Art Unit(s) | 2104, 2102, 2857, 2107, 2819 |
| Total Applications | 941 |
| Issued Applications | 868 |
| Pending Applications | 12 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18452012
[patent_doc_number] => 20230193291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHOD FOR PRODUCING BLOCKPOYMERS BY MEANS OF LINKING BLOCKS BY A TRANSPEPTIDASE, AND BLOCK POLYMERS OBTAINED BY TRANSPEPTIDASE LINKING
[patent_app_type] => utility
[patent_app_number] => 16/630425
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630425 | METHOD FOR PRODUCING BLOCKPOYMERS BY MEANS OF LINKING BLOCKS BY A TRANSPEPTIDASE, AND BLOCK POLYMERS OBTAINED BY TRANSPEPTIDASE LINKING | Jul 9, 2018 | Abandoned |
Array
(
[id] => 16053153
[patent_doc_number] => 20200188431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/620082
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620082 | GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION | Jun 7, 2018 | Abandoned |
Array
(
[id] => 15848011
[patent_doc_number] => 10639264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Mesenchymal stem cell extract and its use
[patent_app_type] => utility
[patent_app_number] => 15/980184
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7720
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/980184 | Mesenchymal stem cell extract and its use | May 14, 2018 | Issued |
Array
(
[id] => 17953709
[patent_doc_number] => 11479803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => b-1, 6-glucanase mutant, and method for measuring b-1, 6-glucan
[patent_app_type] => utility
[patent_app_number] => 16/613487
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6520
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613487 | b-1, 6-glucanase mutant, and method for measuring b-1, 6-glucan | May 10, 2018 | Issued |
Array
(
[id] => 14069497
[patent_doc_number] => 20190083636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I
[patent_app_type] => utility
[patent_app_number] => 15/962636
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962636 | METHODS OF TREATING DISEASES RELATED TO NET FORMATION WITH PARENTERAL ADMINISTRATION OF POLYSIALYLATED DNASE I | Apr 24, 2018 | Abandoned |
Array
(
[id] => 15927947
[patent_doc_number] => 20200155607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => Enriched Cellular Compositions and Therapeutic Use
[patent_app_type] => utility
[patent_app_number] => 16/608285
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608285 | Enriched Cellular Compositions and Therapeutic Use | Apr 24, 2018 | Abandoned |
Array
(
[id] => 16468485
[patent_doc_number] => 20200370022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => MALIGNANT HEMATOPOIETIC CELL MICROCOMPARTMENT AND METHOD FOR PREPARING SUCH A MICROCOMPARTMENT
[patent_app_type] => utility
[patent_app_number] => 16/603264
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603264 | MALIGNANT HEMATOPOIETIC CELL MICROCOMPARTMENT AND METHOD FOR PREPARING SUCH A MICROCOMPARTMENT | Apr 4, 2018 | Abandoned |
Array
(
[id] => 13410199
[patent_doc_number] => 20180256642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => BIOMATERIALS DERIVED FROM TISSUE EXTRACELLULAR MATRIX
[patent_app_type] => utility
[patent_app_number] => 15/913237
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913237 | BIOMATERIALS DERIVED FROM TISSUE EXTRACELLULAR MATRIX | Mar 5, 2018 | Abandoned |
Array
(
[id] => 13397797
[patent_doc_number] => 20180250441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => Perforated Tissue Graft
[patent_app_type] => utility
[patent_app_number] => 15/913152
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913152 | Perforated tissue graft | Mar 5, 2018 | Issued |
Array
(
[id] => 16341650
[patent_doc_number] => 20200306300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
[patent_app_type] => utility
[patent_app_number] => 16/486123
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486123 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | Feb 14, 2018 | Abandoned |
Array
(
[id] => 12838357
[patent_doc_number] => 20180171292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET
[patent_app_type] => utility
[patent_app_number] => 15/896699
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15896699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/896699 | METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET | Feb 13, 2018 | Abandoned |
Array
(
[id] => 13357917
[patent_doc_number] => 20180230498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => High Protein Animal Feed Byproduct From Cereal - Pulse Feedstock Blend Ethanol Production
[patent_app_type] => utility
[patent_app_number] => 15/894862
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15894862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/894862 | High Protein Animal Feed Byproduct From Cereal - Pulse Feedstock Blend Ethanol Production | Feb 11, 2018 | Abandoned |
Array
(
[id] => 13326145
[patent_doc_number] => 20180214610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TISSUE-DERIVED SCAFFOLDING MATERIALS AND METHOD FOR TISSUE FORMATION
[patent_app_type] => utility
[patent_app_number] => 15/885408
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15885408
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/885408 | Tissue-derived scaffolding materials and method for tissue formation | Jan 30, 2018 | Issued |
Array
(
[id] => 15175423
[patent_doc_number] => 20190358303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
[patent_app_type] => utility
[patent_app_number] => 16/482057
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482057 | TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA) | Jan 29, 2018 | Abandoned |
Array
(
[id] => 15083449
[patent_doc_number] => 20190336535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT OCULAR DISEASES AND CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/478523
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478523 | ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT OCULAR DISEASES AND CONDITIONS | Jan 16, 2018 | Abandoned |
Array
(
[id] => 18666493
[patent_doc_number] => 11773371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Skin tissue
[patent_app_type] => utility
[patent_app_number] => 16/481771
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 18
[patent_no_of_words] => 14160
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481771
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481771 | Skin tissue | Jan 16, 2018 | Issued |
Array
(
[id] => 15024077
[patent_doc_number] => 20190323043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => METHOD OF ISOLATING LIPIDS FROM A LIPIDS CONTAINING BIOMASS
[patent_app_type] => utility
[patent_app_number] => 16/473805
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473805 | Method of isolating lipids from a lipids containing biomass | Dec 19, 2017 | Issued |
Array
(
[id] => 16061375
[patent_doc_number] => 10689622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Culture medium for proliferating stem cell, which contains sulfated compound
[patent_app_type] => utility
[patent_app_number] => 15/847246
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23599
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/847246 | Culture medium for proliferating stem cell, which contains sulfated compound | Dec 18, 2017 | Issued |
Array
(
[id] => 15631959
[patent_doc_number] => 10588947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Ultrapure hypoallergenic solutions of sacrosidase
[patent_app_type] => utility
[patent_app_number] => 15/844184
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4392
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/844184 | Ultrapure hypoallergenic solutions of sacrosidase | Dec 14, 2017 | Issued |
Array
(
[id] => 12831949
[patent_doc_number] => 20180169155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => COMPOSITIONS AND METHODS FOR SMALL CANINES
[patent_app_type] => utility
[patent_app_number] => 15/839294
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839294
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/839294 | Compositions and methods for small canines | Dec 11, 2017 | Issued |